• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 13th January 2017

Maynard Matters: A New Publication Covering Alan Maynard’s Contribution to Global Health Economics

Maynard Matters is a new publication edited by Richard Cookson, Maria Goddard and Trevor Sheldon, published by University of York. The publication covers Alan’s contribution to global Health Economics, his thinking about the UK NHS, and his roles as a…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

Maynard Matters is a new publication edited by Richard Cookson, Maria Goddard and Trevor Sheldon, published by University of York. The publication covers Alan’s contribution to global Health Economics, his thinking about the UK NHS, and his roles as a the Founding Director of CHE, the Founding Editor of the journal Health Economics and Chair of York Hospital NHS Foundation Trust.

Maynard Matters is a new publication edited by Richard Cookson, Maria Goddard and Trevor Sheldon, published by University of York, Centre for Health Economics (CHE).

This new publication combines new pieces by leading health economists with extracts from Alan Maynard’s work on efficiency and equity, quality and outcomes, health care financing, markets and competition, workforce, primary care budget holding, pharmaceutical purchasing, and alcohol & drug abuse.

Contributors include OHE’s Research Director Professor Nancy Devlin, OHE Research and Policy Committee member Tony Culyer and past OHE Annual Lecturer Bob Evans. The publication covers Alan’s contribution to global Health Economics, his thinking about the UK NHS, and his role as a the Founding Director of CHE, as the Founding Editor of the journal Health Economics and as Chair of York Hospital NHS Foundation Trust.

One of the papers from Alan in the book, “Performance incentives in general practice”, is his call for GP budget holding at an OHE meeting held in 1985. This paper is part of Health, Education and General Practice (1985), which is available on the OHE website.

In this paper he argues for clearer specification of the basic care package, better information for patients, greater experimentation using pilots of different approaches to running and incentivising GP practices, changes in the doctors contracts, the requirement for all drugs and practices to have proven worth and value for money before being introduced, and community pharmacy to improve GP prescribing as well as for GP fundholding. Each of these ideas has led to a policy implementation, many of which were subsequently shown by researchers to generate benefits.

Alan’s robust approach to using economic thinking to recommend policy to deliver the collective funding of cost-effective health care was also present in his 20th OHE Annual Lecture, which he gave in 2013, five months after release of the Francis Report. This detailed report made 290 recommendations for more regulation. “Sadly”, Maynard notes, “[Francis’s] proposals were not evidenced, not prioritised and not costed”.

UK responses to perceived problems in health care quality, he notes, have produced continuous structural “re-disorganisation” over the past 40 years. These rarely have been evidence based; the disruptions created often were more profound than any improvement.

The alternative to “more regulation (as advocated by lawyers and public inquiries) is better regulation”, according to Alan Maynard. Better regulation, in turn, is based on evidence and economic analysis. Outcomes measurement is at the core of the economic approach to reforming health care. Understanding outcomes, in turn, allows the adoption of effective incentives for change, both financial and non-financial.

Maynard Matters is available for free download as a pdf and as an e-reader here.

A separate CHE web page is also dedicated to stories and messages from friends, colleagues and students.

  • External Publications

Related News

  • News
  • September 2020

Establishing a Reasonable Price for an Orphan Drug

Read more
  • News
  • April 2020

Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support

Read more
  • News
  • April 2020

Financing and Scaling Innovation for the COVID Fight: A Closer Look at Demand-Side Incentives for a Vaccine

Read more
  • News
  • February 2020

Unpacking the Black Box of Payer Policy: A Demand-Side Approach for Equitable Uptake of Cost-Effective Health Innovation

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!